Coated tablet formulation and method

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/00 (2006.01) A61K 9/14 (2006.01) A61K 9/20 (2006.01) A61K 9/28 (2006.01) A61K 31/403 (2006.01)

Patent

CA 2560812

A coated tablet formulation is provided which includes a medicament such as the PPAR / dual agonist peliglitazar or muraglitazar. The coated tablet includes a tablet core containing one or more fillers, one or more binders, one or more disintegrants, and other conventional excipients, and a coating on the tablet core, which coating may include one or more layers, at least one layer of which is formed of medicament and one or more coating polymers, preferably a hydroxypropylmethyl cellulose based polymer. A method for forming the coated tablet via a spray-dried coating technique is also provided.

La présente invention a trait à une formulation de comprimé enrobé comportant un médicament tels que le peliglitazar ou muraglitazar double agoniste des PPAR .alpha./.gamma.. Le comprimé enrobé comporte un noyau de comprimé contenant une ou des charges, un ou des liants, un ou des désintégrants, et d'autres excipients classiques, et un enrobage sur le noyau de comprimé, ledit enrobage pouvant inclure une ou plusieurs couches, au moins une couche qui est formée de médicament et d'une ou de plusieurs polymères d'enrobage, de préférence du polymère à base de d'hydroxypropylméthyle cellulose. L'invention a également trait à un procédé pour la formation du comprimé enrobé grâce à une technique d'enrobage de séchage par pulvérisation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Coated tablet formulation and method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Coated tablet formulation and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coated tablet formulation and method will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1992361

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.